海圣医疗
(920166)
| 流通市值：4.63亿 | | | 总市值：14.67亿 |
| 流通股本：2376.47万 | | | 总股本：7529.41万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 162,345,228.59 | 73,495,192.83 | 345,286,102.13 | 247,713,864.91 |
| 营业总成本 | 128,373,015.8 | 59,956,210.72 | 254,337,555.78 | 183,344,742.23 |
| 其他经营收益 | | | | |
| 营业利润 | 36,099,943.59 | 14,940,972.01 | 97,919,094.93 | 67,306,545.12 |
| 利润总额 | 35,904,702.47 | 14,750,806.84 | 97,744,458.73 | 66,876,850.86 |
| 净利润 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 | 58,782,013.88 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 | 58,782,013.88 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 288,044,781.57 | 294,787,347.82 | 209,176,955.3 | 185,547,648.54 |
| 非流动资产: | | | | |
| 非流动资产合计 | 415,336,775.43 | 410,692,342.3 | 387,333,556.38 | 370,234,078.65 |
| 资产总计 | 703,381,557 | 705,479,690.12 | 596,510,511.68 | 555,781,727.19 |
| 流动负债: | | | | |
| 流动负债合计 | 59,944,507.03 | 61,498,930.99 | 78,401,214.55 | 64,959,138.7 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,269,494.12 | 20,569,676.81 | 20,434,234.8 | 20,377,340.91 |
| 负债合计 | 61,214,001.15 | 82,068,607.8 | 98,835,449.35 | 85,336,479.61 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 642,167,555.85 | 623,411,082.32 | 497,675,062.33 | 470,445,247.58 |
| 股东权益合计 | 642,167,555.85 | 623,411,082.32 | 497,675,062.33 | 470,445,247.58 |
| 负债和股东权益合计 | 703,381,557 | 705,479,690.12 | 596,510,511.68 | 555,781,727.19 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 196,320,288.01 | 109,404,785.68 | 380,952,005.56 | 276,864,260.05 |
| 经营活动现金流出小计 | 186,641,844.74 | 95,670,380.3 | 262,866,934.42 | 193,212,148.17 |
| 经营活动产生的现金流量净额 | 9,678,443.27 | 13,734,405.38 | 118,085,071.14 | 83,652,111.88 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 123,243,966.38 | 39,041,798.63 | 30,138,613.82 | 100,065.87 |
| 投资活动现金流出小计 | 213,721,590.37 | 70,807,914.01 | 107,433,829.89 | 60,216,035.6 |
| 投资活动产生的现金流量净额 | -90,477,623.99 | -31,766,115.38 | -77,295,216.07 | -60,115,969.73 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 130,557,651.52 | 130,557,651.52 | - | - |
| 筹资活动现金流出小计 | 15,403,333.4 | 14,127,978.75 | 3,815,616 | 2,435,042.19 |
| 筹资活动产生的现金流量净额 | 115,154,318.12 | 116,429,672.77 | -3,815,616 | -2,435,042.19 |
| 汇率变动对现金及现金等价物的影响 | -1,020,985.29 | -504,352.4 | -394,173.78 | -169,936.54 |
| 现金及现金等价物净增加额 | 33,334,152.11 | 97,893,610.37 | 36,580,065.29 | 20,931,163.42 |
| 期末现金及现金等价物余额 | 116,646,814.15 | 181,206,272.41 | 83,312,662.04 | 67,663,760.17 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 33,334,152.11 | - | 36,580,065.29 | - |